Another global giant collaborating with capital region
First Roche struck a deal with the Capital Region of Denmark, then followed Novartis, and now a third global drug group has jumped on the bandwagon.
BY STEFAN SINGH KAILAY
MSD Denmark - the Danish unit of US drug giant Merck - the Capital Region of Denmark and University of Copenhagen has struck a collaboration deal set to run for the next five years and aimed at “ensuring more and better clinical research in Denmark,” the pharma group informs.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Novartis: Danish collaboration was an obvious choice
For abonnenter
Here is why Roche opted for Danish partnership
For abonnenter
Lundbeck: Regions prioritize clinical research
For abonnenter
